Nationwide Children's Hospital in Columbus, Ohio, has invested more than $4 million in an intramural funding program over the last 10 years, that is designed to promote, support, and encourage fellows and early-level faculty in conducting clinical and translational research.
Since the pandemic, the U.S. Food and Drug Administration’s Expanded Access pathway has been featured in headlines as a mechanism by which unapproved but potentially beneficial treatments were given to patients outside randomized clinical trials.
With today’s well-known workforce challenges, it is more important than ever for sites to address workforce development in a meaningful way, reimagining the way clinical research department performs in an organizational context.
Dr. Christine Senn, Chair of the ACRP Board of Trustees, shares her outlook on the current state of the Association and the clinical research enterprise.
Improving racial and ethnic diversity of clinical trial participants is essential for generalizable, quality clinical research results and ensuring social and medical equity.